Geoff Meacham
Stock Analyst at Citi
(4.86)
# 362
Out of 4,703 analysts
1198
Total ratings
59.8%
Success rate
17.1%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Maintained: Hold | $260 | $256.46 | +1.38% | 67 | Sep 4, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $585 | $546.12 | +7.12% | 67 | Sep 2, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,600 | $1,149.36 | +39.21% | 100 | Sep 1, 2026 | |
| PTGX Protagonist Therapeutics | Maintained: Buy | $175 → $182 | $145.72 | +24.90% | 13 | Sep 1, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $125 | $103.76 | +20.47% | 17 | Aug 31, 2026 | |
| MRNA Moderna | Maintained: Hold | $60 | $145.55 | -58.78% | 62 | Aug 19, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintained: Buy | $26 → $32 | $34.10 | -6.16% | 21 | Aug 19, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $70 | $66.82 | +4.76% | 73 | Aug 14, 2026 | |
| VOR Vor Biopharma | Maintained: Buy | $50 | $25.05 | +99.60% | 3 | Aug 13, 2026 | |
| ABOS Acumen Pharmaceuticals | Maintained: Buy | $4 | $3.18 | +25.79% | 11 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 | $98.51 | +62.42% | 9 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $345 → $405 | $437.23 | -7.37% | 45 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $60 | $55.33 | +8.44% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $70 | $63.96 | +9.44% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $135 | $117.39 | +15.00% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $28.45 | - | 75 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $165 | $151.00 | +9.28% | 81 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $200 → $215 | $220.83 | -2.64% | 73 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $700 → $740 | $827.72 | -10.60% | 60 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $100 | $77.91 | +28.35% | 18 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $40.05 | +37.33% | 3 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $125 | $150.33 | -16.85% | 64 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 | $10.22 | -31.51% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 | $69.30 | +8.23% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $25.40 | +116.54% | 4 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $170 | $275.23 | n/a | 33 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $1.31 | n/a | 3 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $66.53 | n/a | 35 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $1.57 | n/a | 8 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $55.79 | n/a | 8 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $3.85 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $9 | $14.37 | n/a | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $28.21 | n/a | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $61.16 | n/a | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8653 | n/a | 4 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $15 | $28.65 | n/a | 4 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $49.89 | n/a | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.11 | n/a | 4 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $14 | $11.39 | n/a | 4 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $25 | $20.24 | n/a | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $68.66 | n/a | 1 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $18 | $74.84 | n/a | 6 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $29.66 | n/a | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 → $2 | $5.96 | n/a | 3 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 → $150 | $487.61 | n/a | 15 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $16 | $3.23 | n/a | 2 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $49 | $72.72 | n/a | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $24 | $1.43 | n/a | 6 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $44 | $0.0739 | n/a | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $4 | $18.95 | n/a | 5 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $62 | $1.29 | n/a | 3 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $20 | $16.19 | n/a | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $8.94 | n/a | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $49 → $75 | $9.82 | n/a | 10 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $1.04 | n/a | 1 | Jun 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $32.25 | n/a | 1 | Mar 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $3.86 | n/a | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $9.96 | n/a | 1 | Dec 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $30.06 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.161 | n/a | 1 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $11.99 | n/a | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $65.28 | n/a | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €77.38 | €135.85 | n/a | 1 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 → $32 | $0.1753 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $82 | $126.75 | n/a | 15 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $13 | $4.26 | n/a | 9 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $13.47 | n/a | 3 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $2.46 | n/a | 2 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $103 → $110 | $155.64 | n/a | 11 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $3.71 | n/a | 1 | Mar 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $42.74 | $9.06 | n/a | 6 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $105 | $266.11 | n/a | 8 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $20 → $8 | $29.19 | n/a | 2 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $25 → $16 | $14.08 | n/a | 2 | Oct 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $60 → $90 | $33.10 | n/a | 5 | Dec 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.50 | n/a | 1 | Sep 17, 2012 |
AbbVie
Sep 4, 2026
Maintained: Hold
Price Target: $260
Current: $256.46
Upside: +1.38%
Vertex Pharmaceuticals
Sep 2, 2026
Maintained: Buy
Price Target: $585
Current: $546.12
Upside: +7.12%
Eli Lilly and Company
Sep 1, 2026
Maintained: Buy
Price Target: $1,600
Current: $1,149.36
Upside: +39.21%
Protagonist Therapeutics
Sep 1, 2026
Maintained: Buy
Price Target: $175 → $182
Current: $145.72
Upside: +24.90%
BioNTech SE
Aug 31, 2026
Reiterated: Buy
Price Target: $125
Current: $103.76
Upside: +20.47%
Moderna
Aug 19, 2026
Maintained: Hold
Price Target: $60
Current: $145.55
Upside: -58.78%
Amylyx Pharmaceuticals
Aug 19, 2026
Maintained: Buy
Price Target: $26 → $32
Current: $34.10
Upside: -6.16%
Bristol-Myers Squibb Company
Aug 14, 2026
Maintained: Hold
Price Target: $70
Current: $66.82
Upside: +4.76%
Vor Biopharma
Aug 13, 2026
Maintained: Buy
Price Target: $50
Current: $25.05
Upside: +99.60%
Acumen Pharmaceuticals
Aug 13, 2026
Maintained: Buy
Price Target: $4
Current: $3.18
Upside: +25.79%
Aug 13, 2026
Maintained: Buy
Price Target: $160
Current: $98.51
Upside: +62.42%
Aug 10, 2026
Maintained: Hold
Price Target: $345 → $405
Current: $437.23
Upside: -7.37%
Aug 7, 2026
Maintained: Buy
Price Target: $58 → $60
Current: $55.33
Upside: +8.44%
Aug 6, 2026
Maintained: Buy
Price Target: $66 → $70
Current: $63.96
Upside: +9.44%
Aug 6, 2026
Maintained: Buy
Price Target: $120 → $135
Current: $117.39
Upside: +15.00%
Aug 5, 2026
Maintained: Hold
Price Target: n/a
Current: $28.45
Upside: -
Aug 4, 2026
Reiterated: Buy
Price Target: $165
Current: $151.00
Upside: +9.28%
Aug 3, 2026
Maintained: Hold
Price Target: $200 → $215
Current: $220.83
Upside: -2.64%
Aug 3, 2026
Maintained: Hold
Price Target: $700 → $740
Current: $827.72
Upside: -10.60%
Jul 29, 2026
Maintained: Buy
Price Target: $60 → $100
Current: $77.91
Upside: +28.35%
Jul 16, 2026
Maintained: Buy
Price Target: $55
Current: $40.05
Upside: +37.33%
Jul 15, 2026
Maintained: Hold
Price Target: $125
Current: $150.33
Upside: -16.85%
May 7, 2026
Maintained: Sell
Price Target: $7
Current: $10.22
Upside: -31.51%
May 7, 2026
Maintained: Hold
Price Target: $75
Current: $69.30
Upside: +8.23%
Jan 30, 2026
Maintained: Buy
Price Target: $55
Current: $25.40
Upside: +116.54%
Jun 10, 2024
Maintained: Hold
Price Target: $170
Current: $275.23
Upside: n/a
Jun 6, 2024
Maintained: Buy
Price Target: $22
Current: $1.31
Upside: n/a
Jun 4, 2024
Maintained: Buy
Price Target: $130
Current: $66.53
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: $17
Current: $1.57
Upside: n/a
May 23, 2024
Maintained: Buy
Price Target: $100
Current: $55.79
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $10 → $14
Current: $3.85
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $14 → $9
Current: $14.37
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $36
Current: $28.21
Upside: n/a
May 10, 2024
Maintained: Buy
Price Target: $101
Current: $61.16
Upside: n/a
Mar 15, 2024
Rated: Hold
Price Target: n/a
Current: $0.8653
Upside: n/a
Dec 15, 2023
Downgraded: Hold
Price Target: $23 → $15
Current: $28.65
Upside: n/a
Oct 11, 2023
Maintained: Sell
Price Target: n/a
Current: $49.89
Upside: n/a
Sep 29, 2023
Rated: Hold
Price Target: n/a
Current: $2.11
Upside: n/a
Sep 8, 2023
Downgraded: Hold
Price Target: $23 → $14
Current: $11.39
Upside: n/a
Jul 18, 2023
Reiterated: Buy
Price Target: $35 → $25
Current: $20.24
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $13
Current: $68.66
Upside: n/a
Mar 6, 2023
Reiterated: Buy
Price Target: $13 → $18
Current: $74.84
Upside: n/a
Feb 28, 2023
Reiterated: Hold
Price Target: $23
Current: $29.66
Upside: n/a
Feb 23, 2023
Downgraded: Sell
Price Target: $8 → $2
Current: $5.96
Upside: n/a
Feb 22, 2023
Reiterated: Sell
Price Target: $80 → $150
Current: $487.61
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: $15 → $16
Current: $3.23
Upside: n/a
Feb 17, 2023
Initiated Coverage: Hold
Price Target: $49
Current: $72.72
Upside: n/a
Feb 16, 2023
Reiterated: Sell
Price Target: $2 → $24
Current: $1.43
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $83 → $44
Current: $0.0739
Upside: n/a
Jun 8, 2022
Downgraded: Hold
Price Target: $12 → $4
Current: $18.95
Upside: n/a
May 18, 2022
Reiterated: Buy
Price Target: $75 → $62
Current: $1.29
Upside: n/a
May 17, 2022
Maintained: Buy
Price Target: $28 → $20
Current: $16.19
Upside: n/a
Jan 13, 2022
Reiterated: Buy
Price Target: $60
Current: $8.94
Upside: n/a
Oct 8, 2021
Maintained: Hold
Price Target: $49 → $75
Current: $9.82
Upside: n/a
Jun 8, 2021
Upgraded: Hold
Price Target: n/a
Current: $1.04
Upside: n/a
Mar 19, 2021
Maintained: Buy
Price Target: $35
Current: $32.25
Upside: n/a
Jan 5, 2021
Maintained: Buy
Price Target: $70
Current: $3.86
Upside: n/a
Dec 7, 2020
Reiterated: Buy
Price Target: $9
Current: $9.96
Upside: n/a
Nov 23, 2020
Initiated Coverage: Buy
Price Target: $21
Current: $30.06
Upside: n/a
Sep 8, 2020
Initiated Coverage: Buy
Price Target: $20
Current: $0.161
Upside: n/a
Jun 25, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $11.99
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: $20 → $19
Current: $65.28
Upside: n/a
Feb 20, 2020
Maintained: Hold
Price Target: €77.38
Current: €135.85
Upside: n/a
Dec 3, 2019
Initiated Coverage: Buy
Price Target: $27 → $32
Current: $0.1753
Upside: n/a
May 3, 2019
Downgraded: Hold
Price Target: $90 → $82
Current: $126.75
Upside: n/a
May 2, 2019
Maintained: Hold
Price Target: $13 → $13
Current: $4.26
Upside: n/a
Mar 29, 2019
Maintained: Hold
Price Target: $8
Current: $13.47
Upside: n/a
Mar 29, 2019
Maintained: Buy
Price Target: $27
Current: $2.46
Upside: n/a
Mar 28, 2019
Maintained: Buy
Price Target: $103 → $110
Current: $155.64
Upside: n/a
Mar 11, 2019
Initiated Coverage: Buy
Price Target: $16
Current: $3.71
Upside: n/a
Feb 20, 2019
Rated: Buy
Price Target: $42.74
Current: $9.06
Upside: n/a
Sep 7, 2017
Rated: Buy
Price Target: $80 → $105
Current: $266.11
Upside: n/a
Sep 7, 2017
Rated: Sell
Price Target: $20 → $8
Current: $29.19
Upside: n/a
Oct 23, 2015
Downgraded: Sell
Price Target: $25 → $16
Current: $14.08
Upside: n/a
Dec 2, 2014
Downgraded: Hold
Price Target: $60 → $90
Current: $33.10
Upside: n/a
Sep 17, 2012
Downgraded: Hold
Price Target: n/a
Current: $12.50
Upside: n/a